Unknown

Dataset Information

0

Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.


ABSTRACT: TNF receptor superfamily member 25 (TNFRSF25; also known as DR3, and referred to herein as TNFR25) is constitutively and highly expressed by CD4(+)FoxP3(+) Tregs. However, its function on these cells has not been determined. Here we used a TNFR25-specific agonistic monoclonal antibody, 4C12, to study the effects of TNFR25 signaling on Tregs in vivo in mice. Signaling through TNFR25 induced rapid and selective expansion of preexisting Tregs in vivo such that they became 30%-35% of all CD4(+) T cells in the peripheral blood within 4 days. TNFR25-induced Treg proliferation was dependent upon TCR engagement with MHC class II, IL-2 receptor, and Akt signaling, but not upon costimulation by CD80 or CD86; it was unaffected by rapamycin. TNFR25-expanded Tregs remained highly suppressive ex vivo, and Tregs expanded by TNFR25 in vivo were protective against allergic lung inflammation, a mouse model for asthma, by reversing the ratio of effector T cells to Tregs in the lung, suppressing IL-13 and Th2 cytokine production, and blocking eosinophil exudation into bronchoalveolar fluid. Our studies define what we believe to be a novel mechanism for Treg control and important functions for TNFR25 in regulating autoaggression that balance its known role in enhancing autoimmunity.

SUBMITTER: Schreiber TH 

PROVIDER: S-EPMC2947231 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.

Schreiber Taylor H TH   Wolf Dietlinde D   Tsai Matthew S MS   Chirinos Jackie J   Deyev Vadim V VV   Gonzalez Louis L   Malek Thomas R TR   Levy Robert B RB   Podack Eckhard R ER  

The Journal of clinical investigation 20100920 10


TNF receptor superfamily member 25 (TNFRSF25; also known as DR3, and referred to herein as TNFR25) is constitutively and highly expressed by CD4(+)FoxP3(+) Tregs. However, its function on these cells has not been determined. Here we used a TNFR25-specific agonistic monoclonal antibody, 4C12, to study the effects of TNFR25 signaling on Tregs in vivo in mice. Signaling through TNFR25 induced rapid and selective expansion of preexisting Tregs in vivo such that they became 30%-35% of all CD4(+) T ce  ...[more]

Similar Datasets

| S-EPMC8458693 | biostudies-literature
| S-EPMC6532549 | biostudies-literature
| S-EPMC8217774 | biostudies-literature
| S-EPMC6465521 | biostudies-literature
| S-EPMC6608083 | biostudies-literature
| S-EPMC8843736 | biostudies-literature
| S-EPMC4690809 | biostudies-literature
| S-EPMC10801081 | biostudies-literature
| S-EPMC7882927 | biostudies-literature
| S-EPMC9464972 | biostudies-literature